Federal Initiative to Guarantee Health by Targeting Fentanyl Act

Bill 119 hr 920, also known as the Fentanyl Scheduling Act, aims to make fentanyl-related substances classified as schedule I controlled substances under the Controlled Substances Act. This means that these substances would be considered highly dangerous and have a high potential for abuse, with no accepted medical use.

The bill seeks to address the growing crisis of fentanyl-related overdoses and deaths in the United States. Fentanyl is a powerful synthetic opioid that is 50 to 100 times more potent than morphine and has been responsible for a significant increase in overdose deaths in recent years.

By classifying fentanyl-related substances as schedule I controlled substances, the bill aims to restrict their availability and reduce the likelihood of misuse and abuse. This classification would also make it easier for law enforcement to crack down on the illicit production and distribution of these dangerous substances. In addition to scheduling fentanyl-related substances, the bill also includes provisions for other purposes related to combating the opioid crisis. These may include increased funding for addiction treatment programs, enhanced penalties for trafficking fentanyl, and improved access to naloxone, a medication used to reverse opioid overdoses. Overall, the Fentanyl Scheduling Act is a crucial piece of legislation aimed at addressing the devastating impact of fentanyl-related substances on communities across the United States. By taking proactive measures to classify these substances as schedule I controlled substances, the bill seeks to protect public health and safety and prevent further loss of life due to opioid overdoses.